Order results by:
| Issue | Title | |
| Vol 17, No 1 (2025) | Aggressive multiple sclerosis in the Republic of Bashkortostan | Abstract similar documents |
| K. Z. Bakhtiyarova, U. Sh. Kuzmina, O. V. Lyutov, I. D. Talipova, N. F. Akhmetgaleeva, T. R. Galiullin, M. A. Kutlubaev | ||
| "... Treatment of patients with aggressive multiple sclerosis (MS) characterized by severe progression ..." | ||
| Vol 16 (2024): (Suppl. 2) | Results of tele-rehabilitation in patients with multiple sclerosis during 2020–2021 COVID-19 pandemic | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofeva, A. V. Zotova, V. D. Chukreev, A. Yu. Belkina, L. I. Volkova, M. E. Guseva, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease of the nervous system of a predominantly ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical and epidemiological characteristics of multiple sclerosis in students in the Republic of Bashkortostan | Abstract similar documents |
| A. V. Tukhvatullin, U. Sh. Kuzmina, N. F. Utyagulova, R. F. Talisov, V. A. Vakhitov, K. Z. Bakhtiyarova | ||
| "... An expansion of the age range of multiple sclerosis (MS) manifestation has been reported recently ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Parent-child relationship and family system characteristics in families of adolescents with multiple sclerosis | Abstract similar documents |
| E. A. Boyko, E. V. Ivanchuk, K. R. Latii, V. L. Malygin, O. V. Bykova, T. T. Batysheva | ||
| "... The incidence of multiple sclerosis (MS) is increasing in all age groups, including children ..." | ||
| Vol 13, No 1 (2021) | New possibilities of siponimod therapy in patients with secondary progressive multiple sclerosis | Abstract similar documents |
| D. S. Kasatkin, N. V. Khachanova, V. M. Alifirova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, M. V. Davydovskaya, E. P. Evdoshenko, S. A. Sivertseva | ||
| "... The process of neurodegeneration in multiple sclerosis (MS) remains an urgent problem of modern ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Results of a study of the quality of life in patients with highly active multiple sclerosis in Russia | Abstract similar documents |
| A. N. Boiko, K. Z. Bakhtiyarova, M. A. Sherman, Z. A. Goncharova, I. V. Smagina, T. I. Khaibullin, N. N. Babicheva, N. N. Spirina, I. A. Yampolskaya-Gosteva, I. A. Sokolova, I. V. Greshnova, V. E. Nikitenkova, I. G. Lukashevich, A. V. Inzhinova, N. A. Malkova, D. S. Korobko, O. V. Boyko, I. S. Lozovskaya | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune inflammatory demyelinating and neurodegenerative ..." | ||
| Vol 16 (2024): (Suppl. 2) | Optimization of therapy in secondary progressive multiple sclerosis | Abstract similar documents |
| A. N. Boyko, S. K. Zyryanov, Ya. V. Vlasov | ||
| "... The article provides an analysis of modern methods of treatment of secondary progressive multiple ..." | ||
| Vol 14, No 1S (2022): Спецвыпуск: рассеянный склероз | Rehabilitation of patients with progressive forms of multiple sclerosis | Abstract similar documents |
| S. A. Sivertseva, K. S. Anfilofyeva, A. V. Zotova, A. A. Belkin, M. A. Sherman | ||
| "... Rehabilitation has an important place in the treatment and management of patients with multiple ..." | ||
| Vol 16 (2024): (Suppl. 2) | Multifactorial model of predictors of the development of depressive disorders in multiple sclerosis: a prospective longitudinal study | Abstract PDF (Eng) similar documents |
| K. V. Gubskaia, Yа. V. Malygin, A. Yu. Aleksandrova | ||
| "... Up to 50% of patients with multiple sclerosis (MS) are affected by depression. Objective ..." | ||
| Vol 9, No 1 (2017) | Clinical and epidemiological features of patients with multiple sclerosis in the Kursk Region | Abstract similar documents |
| V. B. Laskov, E. A. Logacheva, E. E. Tretyakova, M. A. Gridnev | ||
| "... Objective: to analyze the regional register of patients with multiple sclerosis (MS) in the Kursk ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | The central vein sign in the differential diagnosis of multiple sclerosis | Abstract similar documents |
| S. E. Belov, A. N. Boyko | ||
| "... The current diagnosis of multiple sclerosis (MS) is based on confirmation of the disseminated ..." | ||
| Vol 15 (2023): (Suppl. 1) | The place of virtual reality in the rehabilitation of patients with multiple sclerosis | Abstract similar documents |
| Iu. E. Korzhova, A. A. Fuks, A. S. Klochkov, A. E. Khizhnikova, N. A. Suponeva, M. N. Zakharova | ||
| "... Multiple sclerosis (MS) is a chronic autoimmune disease that limits the ability to work and lead ..." | ||
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... Patients with multiple sclerosis (MS) are at high risk for transition to secondary progressive MS ..." | ||
| Vol 16 (2024): (Suppl. 2) | Analysis of the experience with once-weekly intramuscular administration of interferon beta-1a in the Russian population of patients with relapsing-remitting multiple sclerosis | Abstract similar documents |
| F. A. Khabirov, E. V. Granatov, A. Ya. Dykhanov, T. I. Khaibullin | ||
| "... administration, which has moderate efficacy in reducing clinical exacerbations of multiple sclerosis (MS), which ..." | ||
| Vol 12, No 1S (2020): Спецвыпуск: рассеянный склероз | Age at onset in multiple sclerosis as a possible predictor for cognitive impairment in children and adolescents | Abstract similar documents |
| M. D. Bogdanova, T. T. Batysheva, Yu. V. Mikadze, R. Ts. Bembeeva, E. Yu. Volkova | ||
| "... Pediatric-onset multiple sclerosis (MS) can lead to cognitive impairment (CI). In general ..." | ||
| Vol 11, No 3 (2019) | Clinical recommendations for the use of ocrelizumab in patients with multiple sclerosis | Abstract similar documents |
| A. N. Boyko, M. V. Davydovskaya, N. V. Khachanova, M. N. Zakharova, N. N. Spirin, E. V. Popova, V. M. Alifirova, Ya. V. Vlasov, S. A. Sivertseva, F. A. Khabirov, M. V. Shumilina, E. P. Evdoshenko | ||
| "... multiple sclerosis and primary progressive multiple sclerosis in the use of ocrelizumab. ..." | ||
| Vol 8, No 3 (2016) | Cardiointervalography in patients with multiple sclerosis | Abstract similar documents |
| A. R. Rakhmatullin, K. Z. Bakhtiyarova, R. V. Magzhanov | ||
| "... Cardiovascular autonomic symptoms significantly impart quality of life in patients with multiple ..." | ||
| Vol 7, No 1 (2015) | Time course of changes in the development of gait disorders in multiple sclerosis | Abstract similar documents |
| A. M. Petrov, I. D. Stolyarov, G. G. Shkilnyuk, A. G. Ilves, K. K. Mineev, V. V. Lebedev, T. L. Tsvetkova | ||
| "... Objective: to estimate the time course of changes in foot biomechanical function as multiple ..." | ||
| Vol 16 (2024): (Suppl. 2) | Curcumin as an add-on therapy for multiple sclerosis in patients receiving interferon-beta therapy | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaya, E. V. Lysogorskaia, A. N. Boyko | ||
| "... Search for agents for the add-on therapy of multiple sclerosis (MS) that can enhance the effect ..." | ||
| Vol 6, No 3 (2014) | Visual evoked potentials in examining the visual analyzer in patients with multiple sclerosis | Abstract similar documents |
| S. M. Karpov, Z. B. Pazhigova, E. N. Karpova | ||
| "... with multiple sclerosis (MS) to optimize the early diagnosis of the disease. Patients and methods. Seventy-nine ..." | ||
| Vol 17, No 4 (2025) | Hyperhomocysteinemia and endothelial dysfunction in multiple sclerosis | Abstract similar documents |
| E. A. Dubchenko, A. N. Boyko, A. V. Ivanov, M. A. Popov, R. A. Maslennikov, M. P. Kruglova, E. V. Silina, E. I. Gusev, A. A. Kubatiev | ||
| "... For a comprehensive study of such a socially significant disease as multiple sclerosis (MS), which ..." | ||
| Vol 15 (2023): (Suppl. 1) | MicroRNAs as biomarkers of multiple sclerosis progression | Abstract similar documents |
| N. M. Baulina, I. S. Kiselev, O. G. Kulakova, E. V. Popova, O. O. Favorova, A. N. Boyko | ||
| "... Multiple sclerosis (MS) is an autoimmune inflammatory neurodegenerative disease of the central ..." | ||
| Online-first | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... In recent years, the incidence of multiple sclerosis (MS) has increased in the pediatric ..." | ||
| Vol 17, No 1 (2025) | The first experience with the use of ofatumumab for the treatment of pediatric multiple sclerosis in real-life clinical practice in Russia. A case series | Abstract similar documents |
| E. D. Kuzminykh, V. M. Lebedev, V. E. Senchenko, M. S. Cherepyansky, V. A. Gonchar, D. S. Korobko | ||
| "... In recent years, the incidence of multiple sclerosis (MS) has increased in the pediatric ..." | ||
| Vol 12, No 3 (2020) | Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis | Abstract similar documents |
| K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. V. Davydovskaya, M. N. Zakharova, N. A. Malkova, A. I. Nilov, S. A. Sivertseva, N. N. Spirin, N. A. Totolyan, F. A. Khabirov, M. V. Shumilina | ||
| "... Currently, special attention is paid to timely treatment for active forms of multiple sclerosis ..." | ||
| Vol 12, No 5 (2020) | Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets | Abstract similar documents |
| N. A. Totolyan, V. M. Alifirova, K. Z. Bakhtiyarova, A. N. Boyko, Ya. V. Vlasov, Z. A. Goncharova, M. N. Zakharova, D. S. Kasatkin, S. V. Kotov, A. I. Nilov, S. A. Sivertseva, A. A. Sokolova, N. N. Spirin, F. A. Khabirov, D. Paradnika | ||
| "... The need for optimal treatment of the active forms of multiple sclerosis (MS), especially highly ..." | ||
| Vol 11, No 4 (2019) | Recommendations from the Expert Meeting «Secondary progressive multiple sclerosis: unresolved issues and prospects» | Abstract similar documents |
| N. V. Khachanova, A. N. Boyko, K. Z. Bakhtiyarova, Ya. V. Vlasov, E. P. Evdoshenko, S. A. Sivertseva, T. E. Schmidt, M. V. Shumilina | ||
| "... progressive multiple sclerosis (MS) (SPMS), clinical trials, and promising treatments for the progressive MS ..." | ||
| Vol 17, No 4 (2025) | Cognitive changes in multiple sclerosis and factors of their development: association with taking disease-modifying therapies | Abstract similar documents |
| A. O. Komissarenko, V. V. Grinyuk, A. S. Bakhchivanov, E. V. Yashchuk, E. S. Fatueva, K. Yu. Komissarenko, N. V. Vakhnina, V. V. Zakharov, N. S. Babieva | ||
| "... Currently, there is an increase in the life expectancy of patients with multiple sclerosis (MS ..." | ||
| Vol 12, No 3 (2020) | Vitamin D status in patients with multiple sclerosis: an association with insolation, disease course, and HLA-DRB1 gene polymorphism | Abstract PDF (Eng) similar documents |
| I. V. Smagina, K. V. Lunev, S. A. Elchaninova | ||
| "... on the relationship of multiple sclerosis (MS) to vitamin D supplementation Objective: to assess the relationship ..." | ||
| Vol 15, No 6 (2023) | Ofatumumab – the first fully human monoclonal antibody approved for the treatment of multiple sclerosis | Abstract similar documents |
| E. V. Popova | ||
| "... Currently, more than 15 molecules are already approved for the treatment of multiple sclerosis ..." | ||
| Vol 16, No 6 (2024) | Characteristics of the parent-child relationship in families of children with cerebral palsy and multiple sclerosis (literature review) | Abstract similar documents |
| E. A. Boiko, V. L Malygin, E. I. Glushchenko | ||
| "... Multiple sclerosis (MS) and cerebral palsy (CP) are chronic disabling diseases caused by central ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Genome-wide polygenic analysis of multiple sclerosis markers | Abstract similar documents |
| Ya. R. Timasheva, T. R. Nasibullin, I. A. Tuktarova, V. V. Erdman, T. R. Galiullin, O. V. Zaplakhova, K. Z. Bakhtiiarova | ||
| "... Objective: to perform a genome-wide polygenic analysis of multiple sclerosis (MS) markers ..." | ||
| Vol 17, No 3 (2025) | Curcumin as add-on therapy in patients with multiple sclerosis showing a suboptimal response to first-line disease-modifying therapies: clinical outcomes and in vitro data | Abstract similar documents |
| A. D. Kukushkina, V. S. Rogovskii, E. V. Ponevezhskaia, E. V. Lysogorskaia, A. N. Boyko | ||
| "... In recent decades, pathogenetic therapy of multiple sclerosis (MS) has advanced significantly due ..." | ||
| Vol 17, No 3 (2025) | Multiple sclerosis associated with adalimumab: a case report and systematic review | Abstract similar documents |
| A. A. Tappakhov, T. Ya. Nikolaeva, N. Yu. Gorokhova, L. T. Okoneshnikova, A. N. Ylakhova, E. E. Konnikova | ||
| "... The role of medications as risk factors for the development of multiple sclerosis (MS) remains ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Art therapy possibilities in the complex treatment of patients with multiple sclerosis | Abstract similar documents |
| M. E. Guseva, O. V. Matvievskaya, A. N. Boyko | ||
| "... -progressive multiple sclerosis (MS). Patients and methods. A group of 42 patients (5 men and 37 women, mean ..." | ||
| Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
| "... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..." | ||
| Vol 16 (2024): (Suppl. 2) | Sampeginterferon beta-1a in clinical practice | Abstract similar documents |
| I. A. Sokolova, O. S. Kornakova, E. V. Sokolova | ||
| "... In multiple sclerosis (MS), the development and introduction of disease-modifying treatments (DMTs ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Attitude to reproduced disease modifying therapies in patients with relapsing-remitting multiple sclerosis: results of a medical and sociological study | Abstract similar documents |
| Ya. V. Vlasov, M. V. Churakov, E. V. Sineok, A. N. Boyko | ||
| "... The problem of an adequate choice of a treatment method in multiple sclerosis (MS) remains one ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic | Abstract similar documents |
| E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov | ||
| "... institutions in terms of research for new multiple sclerosis (MS) treatments. In this review we discuss ..." | ||
| Vol 15, No 4 (2023) | Paramagnetic rim sign in multiple sclerosis | Abstract similar documents |
| D. V. Kapkanets, S. E. Belov, M. B. Dolgushin, A. N. Boyko | ||
| "... To date, there is no accepted highly specific pattern for the detection of multiple sclerosis ..." | ||
| Vol 16, No 3 (2024) | Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra | Abstract similar documents |
| A. A. Sokolova, L. I. Anischenko, L. S. Zemlyanushin, E. A. Rubtsova | ||
| "... Cladribine is a tablet preparation for the treatment of relapsing-remitting multiple sclerosis ..." | ||
| Vol 16 (2024): (Suppl. 2) | Combined analysis of free kappa chains and central vein sign increases the specificity of multiple sclerosis diagnosis | Abstract similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... ) in the diagnosis of multiple sclerosis (MS). Material and methods. Eighty patients participated in the study ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Clinical presentation and course of multiple sclerosis in patients with herpesvirus infection | Abstract similar documents |
| M. S. Gris, N. S. Baranova, N. N. Spirin, D. S. Kasatkin, D. V. Kiselev, E. G. Shipova | ||
| "... for multiple sclerosis (MS) in the presence of persistent herpesvirus infection (PHVI) remain poorly understood ..." | ||
| Vol 15 (2023): (Suppl. 1) | Contribution of B-lymphocytes to the production of Interleukin-17 in multiple sclerosis | Abstract similar documents |
| N. V. Sursyakova, E. M. Kuklina, T. V. Baidina, I. V. Nekrasova, T. N. Trushnikova | ||
| "... The study of pathogenic systems involved in multiple sclerosis (MS) is essential ..." | ||
| Vol 13, No 2 (2021) | COVID-19 vaccination guidelines for patients with multiple sclerosis | Abstract similar documents |
| N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko | ||
| "... with multiple sclerosis (MS) is presented. The authors of the consensus, based on an analysis of a large number ..." | ||
| Vol 8, No 4 (2016) | GLATIRAMER ACETATE IS A FIRST-LINE DUAL-ACTION DRUG FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS | Abstract similar documents |
| T. E. Shmidt | ||
| "... Multiple sclerosis (MS) is the most common and potentially disabling disease of the central ..." | ||
| Vol 13, No 3 (2021) | Results of Expert Council meeting on modern principles of treatment optimization in patients with relapsing-remitting multiple sclerosis using anti-CD20 monoclonal antibody | Abstract similar documents |
| A. N. Boyko, N. V. Khachanova, D. S. Korobko, D. S. Kasatkin, Ya. V. Vlasov, E. P. Evdoshenko, E. V. Popova, K. Z. Bakhtiyarova, S. A. Sivertseva | ||
| "... The article presents the results of the discussion of the use of anti-B-cell therapy in multiple ..." | ||
| Vol 10, No 2 (2018) | CLIPPERS syndrome | Abstract similar documents |
| T. E. Schmidt, I. N. Pronin, K. Yu. Kazantsev, O. N. Voskresenskaya, I. V. Damulin, A. A. Aleksandrov, N. N. Yakhno | ||
| Vol 17, No 4 (2025) | The role of central vein sign in differential diagnostics of neuromyelitis optica spectrum disorders and multiple sclerosis | Abstract similar documents |
| S. V. Kotov, E. S. Novikova, G. T. Tonya, A. S. Kotov | ||
| "... spectrum disorders (NMOSD) and multiple sclerosis (MS). The presence of central vein sign (CVS) in areas ..." | ||
| Vol 16, No 3 (2024) | Concentration of immunoglobulin free light chains in cerebrospinal fluid in the diagnosis of multiple sclerosis | Abstract PDF (Eng) similar documents |
| Sh. R. Nabiev, S. A. Dzhukkaeva, M. Sh. Asvedov, D. E. Prokhorov, E. V. Popova, V. V. Grinyuk, P. R. Magomadova, A. R. Apevalova, O. N. Voskresenskaya | ||
| "... of multiple sclerosis (MS). Material and methods. 80 patients participated in the study. The main group ..." | ||
| Vol 15, No 6 (2023) | MRI assessment of different types of chronic demyelinating lesions in patients with multiple sclerosis using quantitative susceptibility mapping (QSM) | Abstract similar documents |
| M. S. Matrosova, V. V. Bryukhov, E. V. Popova, G. N. Belskaya, M. V. Krotenkova | ||
| "... Histologically, chronic demyelinating lesions in multiple sclerosis (MS) have been shown ..." | ||
| Vol 16, No 3 (2024) | Diffusion tensor tomography with tractography in assessment of the pyramidal system in patients with highly active multiple sclerosis | Abstract similar documents |
| A. N. Peshkin, G. T. Toniya, E. A. Stepanova, V. Yu. Lizhdvoi, S. V. Kotov | ||
| "... Objective: to study the pyramidal tract in patients with highly active multiple sclerosis (HAMS ..." | ||
| Vol 17, No 4 (2025) | The role of noradrenaline in regulating the interaction between CD14+ monocytes and CD4+ T cells in multiple sclerosis | Abstract similar documents |
| D. V. Nikolaeva, R. R. Zhetishev, A. V. Lopatina, A. A. Sviridova, D. D. Esipova, N. E. Murugina, V. V. Murugin, A. N. Boiko, M. V. Melnikov | ||
| "... Multiple sclerosis (MS) is an autoimmune demyelinating and neurodegenerative disease ..." | ||
| Vol 16 (2024): (Suppl. 2) | Experience with the use of cladribine tablets in real-life clinical practice: independent analysis of data from 12 Russian clinical centres | Abstract similar documents |
| A. N. Boyko, V. M. Alifirova, D. V. Pashkovskaya, E. I. Kuchina, S. A. Sivertseva, E. L. Turova, Z. A. Goncharova, O. Yu. Rudenko, Yu. Yu. Pogrebnova, F. A. Khabirov, T. I. Khaibullin, N. N. Babicheva, N. L. Khoroshilova, O. V. Dzundza, O. A. Soldatova, A. N. Belova, G. Е. Sheiko, A. Е. Makarova, N. G. Glavinskaya | ||
| "... Multiple sclerosis (MS) is an autoimmune-inflammatory and neurodegenerative disease of the central ..." | ||
| Vol 15 (2023): (Suppl. 1) | Delayed diagnosis of the neuromyelitis optica spectrum disorder | Abstract similar documents |
| S. A. Dzhukkaeva, E. V. Ermilova, Sh. R. Nabiev, O. N. Voskresenskaya | ||
| Vol 17, No 2 (2025) | Multitarget transcranial magnetic theta-burst stimulation in the correction of cognitive impairment in patients with progressive multiple sclerosis | Abstract PDF (Eng) similar documents |
| A. Kh. Zabirova, I. S. Bakulin, A. G. Poydasheva, D. Yu. Lagoda, M. N. Zakharova, E. V. Gnedovskaya, N. A. Suponeva, M. A. Piradov | ||
| "... Cognitive impairment (CI) is a common symptom in multiple sclerosis (MS) that significantly ..." | ||
| Vol 15 (2023): (Suppl. 1) | Clinical course features of atypical demyelinating optic neuritis: case series | Abstract similar documents |
| N. L. Sheremet, D. D. Eliseeva, V. V. Bryukhov, N. A. Andreeva, N. V. Zhorzholadze, Yu. K. Murakhovskaya, A. K. Kalashnikova, M. N. Zakharova | ||
| "... associated with multiple sclerosis (MS), and atypical ON, which are the main clinical manifestation ..." | ||
| Vol 16, No 3 (2024) | Optic neuritis in various demyelinating diseases | Abstract PDF (Eng) similar documents |
| A. K. Kalashnikova, D. D. Eliseeva, N. A. Andreeva, N. V. Zhorzholadze, I. A. Ronzina, R. Ts. Bembeeva, N. N. Venediktova, M. R. Kalganova, N. L. Sheremet | ||
| "... glycoprotein (MOG) confirmed the existence of two disease entities distinct from multiple sclerosis (MS ..." | ||
| Vol 12, No 3 (2020) | Anti-MOG associated myelitis | Abstract PDF (Eng) similar documents |
| A. I. Isaykin, O. N. Voskresenskaya, T. I. Kuzminova, E. V. Ermilova, O. V. Stezhko | ||
| "... of anti-MOG associated myelitis at the CI-TXlevel. Differential diagnosis was made between multiple ..." | ||
| 1 - 59 of 59 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
